hims retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi LLY $NVO $HIMS 🚨 BREAKING:

Phase 4 (Post-Marketing): Monitors long-term safety, effectiveness, and rare side effects after the drug reaches the market

Electrolyte supplementation becomes important if youre experiencing GI side effects

Additionally, Therefore, its best to pair GLP-1 agonists with modifications to your diet and lifestyle

Retatrutide has no MHRA marketing authorisation and cannot be legally prescribed, dispensed, or sold in the UK

For those in a maintenance phase after weight loss, microdosing can help preserve metabolic gains without the appetite suppression of higher doses, prioritizing sustainability , tolerability , and resilience important for long-term health optimization

Introduction: the state of obesity in 2023